<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:43:36Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/12973" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/12973</identifier><datestamp>2026-10-18T21:13:23Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Combined effects of bone morphogenetic protein-7 and mineral trioxide aggregate on the proliferation, migration, and differentiation of human dental pulp stem cells</dc:title><dc:creator>Küçükkaya Eren, Selen</dc:creator><dc:creator>Bahador Zirh, Elham</dc:creator><dc:creator>Zirh, Selim</dc:creator><dc:creator>Sharafi, Parisa</dc:creator><dc:creator>Zeybek, Naciye Dilara</dc:creator><dc:subject>Calcium silicate</dc:subject><dc:subject>Cytotoxicity</dc:subject><dc:subject>Osteogenic protein-1</dc:subject><dc:subject>Pulpotomy</dc:subject><dc:subject>Regenerative endodontics</dc:subject><dc:subject>Aluminum Compounds</dc:subject><dc:subject>Bone Morphogenetic Protein 7</dc:subject><dc:subject>Calcium Compounds</dc:subject><dc:subject>Cell Proliferation</dc:subject><dc:subject>Dental Pulp</dc:subject><dc:subject>Drug Combinations</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Osteogenesis</dc:subject><dc:subject>Oxides</dc:subject><dc:subject>Pemetrexed</dc:subject><dc:subject>Silicates</dc:subject><dc:subject>Stem Cells</dc:subject><dc:subject>aluminum derivative</dc:subject><dc:subject>calcium derivative</dc:subject><dc:subject>mineral trioxide aggregate</dc:subject><dc:subject>osteogenic protein 1</dc:subject><dc:subject>oxide</dc:subject><dc:subject>silicate</dc:subject><dc:subject>bone development</dc:subject><dc:subject>drug combination</dc:subject><dc:subject>human</dc:subject><dc:subject>stem cell</dc:subject><dc:subject>tooth pulp</dc:subject><dc:description>Bioactive molecules present the potential to be used along with biomaterials in vital pulp therapy and regenerative endodontic treatment. Objective: The aim of this study was to assess the effects of the combined use of bone morphogenetic protein-7 (BMP-7) and mineral trioxide aggregate (MTA) on the proliferation, migration, and differentiation of human dental pulp stem cells (DPSCs). Methodology: For the proliferation analysis, DPSCs were incubated with a growth medium and treated with MTA and/or BMP-7 at different concentrations. For the following analyses, DPSCs were incubated with a differentiation medium and treated with MTA and/ or BMP-7. Moreover, there were groups in which DPSCs were incubated with the growth medium (control), the differentiation medium, or DMEM/F12 containing fetal bovine serum, and not treated with MTA or BMP-7. Cell proliferation was analyzed using the WST-1 assay. The odontogenic/osteogenic differentiation was evaluated by immunocytochemistry, alkaline phosphatase (ALP) activity assay, alizarin red staining, and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Cell migration was evaluated using a wound-healing assay. Data were analyzed using analysis of variance and Tukey test (p=0.05). Results: The use of BMP-7 with MTA presented no significant effect on cell proliferation in comparison with the treatment with MTA alone (p&gt;0.05), but showed higher ALP activity, increased mineralization, and higher expression of DMP1 and DSPP when compared with other groups (p&lt;0.05). Nestin expression was higher in the control group than in groups treated with MTA and/or BMP-7 (p&lt;0.05). The cell migration rate increased after treatment with MTA when compared with other groups in all periods of time (p&lt;0.05). At 72 hours, the wound area was smaller in groups treated with MTA and/ or BMP-7 than in the control group (p&lt;0.05). Conclusion: The use of BMP-7 with MTA increased odontogenic/osteogenic differentiation without adversely affecting proliferation and migration of DPSCs. The use of BMP-7 with MTA may improve treatment outcomes by increasing repair and regeneration capacity of DPSCs. © 2022, Faculdade de Odontologia de Bauru da Universidade de Sao Paulo. All rights reserved.</dc:description><dc:publisher>Faculdade de Odontologia de Bauru da Universidade de Sao Paulo</dc:publisher><dc:date>2022</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/12973</dc:identifier><dc:identifier>https://doi.org/10.1590/1678-7757-2022-0086</dc:identifier><dc:identifier>1678-7757</dc:identifier><dc:language>en</dc:language><dc:relation>Journal of Applied Oral Science</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/12973</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>